Spero Therapeutics, Inc. (SPRO): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$157.0K
Year ended 2020-12-31
+79.8%
3-year compound annual growth
-7.5%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $157.0K | -50.0% | 2021-03-11, From 2020-01-01 |
| 2019-12-31 | $314.0K | -87.1% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $2.44M | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $27.0K | -96.7% | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | $830.0K | +257.8% | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | $232.0K | n/a | 2018-04-02, From 2015-01-01 |